Form D · Biotechnology

SUTRO BIOPHARMA INC

South San Francisco, CA · CIK 0001382101

Offering snapshot reported Aug 8, 2018 · SEC filing

Reported sold
$85.4M
Offering amount: $85.4M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 24, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$42.7M$85.4MJun 6, 2018: $31,624,999.00Jun 6, 2018Aug 8, 2018: $85,382,349.00Aug 8, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$31,624,999 → $85,382,349
  • Reported investors8 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 8, 2018Amendment$85,382,349$53,757,350vs Jun 6, 201815SEC filing
Jun 6, 2018Initial$31,624,999No comparison8SEC filing
Oct 24, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Dec 29, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Nov 8, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-314024

Source: Form D, filed Aug 8, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Dybbs Director
John G. Freund Director
Daniel Janney Director
Bryan Lawlis Director
Virgil Bryan Lawlis Director
Joseph Lobacki Director
William J. Newell Director, Executive
Daniel Petree Director
Michael Ross Director
Armen Shanafelt Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
310 Utah Ave., Suite 150
South San Francisco, CA, 94080